# Fasting Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets

> **NCT00853216** · PHASE1 · COMPLETED · sponsor: **Mallinckrodt** · enrollment: 38 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Oxycodone hydrochloride tablet 30 mg
- **DRUG:** Roxicodone™ tablet 30 mg

## Key facts

- **NCT ID:** NCT00853216
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2003-02
- **Final completion:** 2003-02
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00853216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00853216, "Fasting Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00853216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*